Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02192307 · ClinicalTrials.gov registry record · NA

Effectiveness of Two Water-Based Potassium Oxalate Desensitizers

A NA study of Dentin Sensitivity, sponsored by Procter and Gamble.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT02192307: Completed NA study of Dentin Sensitivity, sponsored by Procter and Gamble.

NCT02192307 is a NA study of Dentin Sensitivity that has completed, run by Procter and Gamble. The registered enrollment target is 60 participants, below the 257-participant average among 3 other Dentin Sensitivity trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02192307, a NA study of Dentin Sensitivity, has completed, sponsored by Procter and Gamble.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study will compare the safety and effectiveness of two water-based potassium oxalate desensitizers on existing dentinal hypersensitivity.

Primary Outcome

The Schiff Sensitivity Scale was assessed for each test tooth via an evaporative air challenge. The examiner recorded the Schiff Index score corresponding to the response to the air challenge. The Schiff Index Sensitivity scale is scored as follows- 0: tooth/subject did not respond to stimulus, 1: tooth/subject responds to stimulus, but does not request discontinuation of stimulus, 2: tooth/subject responds to stimulus and requests discontinuation or moves form stimulus, 3: tooth/subject respond

Conditions Studied

Interventions

  • DEVICE Potassium oxalate

Study Locations (1)

Massachusetts

  • Tufts University School of Dental Medicine - Boston

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2014-07
Est. Completion 2014-09
Phase NA
Procter and Gamble

70 total trials

What the finished NCT02192307 record still lists

NCT02192307 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 257-participant average among 3 other Dentin Sensitivity trials with a reported enrollment target (77% lower).

The record links to 1 condition, with Dentin Sensitivity appearing as the primary indexed condition, and to 1 intervention - of which Potassium oxalate is the first listed.

NCT02192307 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02192307 about?

NCT02192307 is a clinical study titled "Effectiveness of Two Water-Based Potassium Oxalate Desensitizers". This study will compare the safety and effectiveness of two water-based potassium oxalate desensitizers on existing dentinal hypersensitivity.

What is the current status of trial NCT02192307?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2014-07. Estimated completion is 2014-09.

What conditions does trial NCT02192307 study?

This clinical trial studies the following conditions: Dentin Sensitivity.

What interventions are being tested in trial NCT02192307?

The interventions under investigation include: Potassium oxalate (DEVICE).

Who is sponsoring clinical trial NCT02192307?

This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02192307 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dentin Sensitivity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02192307, the US trial registry maintained by the National Library of Medicine. NCT02192307 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.